c("cell line: SKOV3ip1", "cell type: ovarian adenocarcinoma", "growth protocol: grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: none")
c("cell line: SKOV3ip1", "cell type: ovarian adenocarcinoma", "growth protocol: grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: none")
c("cell line: MCF7", "cell type: breast adenocarcinoma", "growth protocol: grown in EMEM (Wisent) supplemented with 1 mM sodium pyruvate and MEM nonessential amino acid (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: none")
c("cell line: MCF7", "cell type: breast adenocarcinoma", "growth protocol: grown in EMEM (Wisent) supplemented with 1 mM sodium pyruvate and MEM nonessential amino acid (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: none")
c("cell line: BJ-Tielf", "cell type: immortalized normal skin fibroblast", "growth protocol: grown in alpha-MEM (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: none")
c("cell line: BJ-Tielf", "cell type: immortalized normal skin fibroblast", "growth protocol: grown in alpha-MEM (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: none")
c("cell line: INOF", "cell type: immortalized normal ovarian fibroblast", "growth protocol: grown in OSE medium (Wisent) , supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: none")
c("cell line: INOF", "cell type: immortalized normal ovarian fibroblast", "growth protocol: grown in OSE medium (Wisent) , supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: none")
c("cell line: SKOV3ip1", "cell type: ovarian adenocarcinoma", "growth protocol: grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: Lipofectamine 2000 treated")
c("cell line: SKOV3ip1", "cell type: ovarian adenocarcinoma", "growth protocol: grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: Lipofectamine 2000 treated")
c("cell line: SKOV3ip1", "cell type: ovarian adenocarcinoma", "growth protocol: grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: Lipofectamine 2000 treated")
c("cell line: SKOV3ip1", "cell type: ovarian adenocarcinoma", "growth protocol: grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: Treated with siRNA targeting NOP58 (CUUCUACCGUUCAGAUUCU). Transfection was performed in suspension using Lipofectamine 2000 (Life technologies) according to the manufacturer’s protocol and 20 nM of siRNA (Sigma) for 48 hours.")
c("cell line: SKOV3ip1", "cell type: ovarian adenocarcinoma", "growth protocol: grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: Treated with siRNA targeting NOP58 (GACAAGUCCCAAACACAAA). Transfection was performed in suspension using Lipofectamine 2000 (Life technologies) according to the manufacturer’s protocol and 20 nM of siRNA (Sigma) for 48 hours.")
c("cell line: SKOV3ip1", "cell type: ovarian adenocarcinoma", "growth protocol: grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: Treated with siRNA targeting RBFOX2 (GAUGGUCACACCAUAUGCA). Transfection was performed in suspension using Lipofectamine 2000 (Life technologies) according to the manufacturer’s protocol and 20 nM of siRNA (Sigma) for 48 hours.")
c("cell line: SKOV3ip1", "cell type: ovarian adenocarcinoma", "growth protocol: grown in DMEM/F12 (50/50) medium (Wisent), supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC", "treatment: Treated with siRNA targeting RBFOX2 (CACCUCCGCAGAAUGGAAU). Transfection was performed in suspension using Lipofectamine 2000 (Life technologies) according to the manufacturer’s protocol and 20 nM of siRNA (Sigma) for 48 hours.")